NCT02157779

Brief Summary

Excessive and poorly controlled anger is one of the most common problems experienced by war Veterans. The consequences can be severe, including increased risk for divorce, domestic violence, job loss and instability, and other serious impairments in family, social, and occupational functioning. Availability of effective treatments is critical to reducing the adverse effects of anger in Veterans. The investigators propose to conduct a controlled study to determine whether a cognitive behavior treatment that has been adapted for treating anger problems in Veterans of Iraq and Afghanistan results in improved outcomes compared to a supportive therapy. Results will be examined for improvement in anger, functioning, and quality of life at end of 12 weekly sessions, and at 3 and 6 months following treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 6, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2019

Completed
1 year until next milestone

Results Posted

Study results publicly available

March 16, 2020

Completed
Last Updated

November 18, 2021

Status Verified

October 1, 2021

Enrollment Period

4.2 years

First QC Date

May 6, 2014

Results QC Date

February 26, 2020

Last Update Submit

October 20, 2021

Conditions

Keywords

VeteransAngerCognitive Behavioral TherapyTreatment

Outcome Measures

Primary Outcomes (2)

  • Least Squares Mean Anger Expression Index Score on the State Trait Anger Inventory 2 (STAXI-2) Using a Repeated Measures ANCOVA Adjusted for Baseline and Time Effects

    The STAXI-2 is a revision of Spielberger's State-Trait Anger Expression Inventory (STAXI), expanded from 44 to 57 items. It is a self-report questionnaire consisting of six scales and an Anger Expression Index (AX). Scales include State Anger, Trait Anger, Anger Expression-Out, Anger Expression-In, Anger Control-Out and Anger Expression-In. The Anger Expression Index is an overall measure of the expression and control of anger based on responses to the two anger expression and the two anger control subscales. Minimum and Maximum Values range from 0 to 96, higher scores mean more anger.

    Baseline, Weeks 4, 8,12, 3 and 6 months post-treatment

  • Least Squares Mean Aggression Scale Score on the Overt Aggression Scale-Modified (OAS-M) Using a Repeated Measures ANCOVA Adjusted for Baseline Scores and Time Effects

    Structured Interview that assesses verbal and physical aggressive behaviors. Minimum and Maximum Values range from 0 to no maximum, higher scores mean more anger.

    Baseline, Weeks 4, 8,12 (end of treatment), 3 and 6 months post-treatment

Secondary Outcomes (5)

  • Least Squares Mean Global Social Adjustment Score on the Longitudinal Interval Follow-up Evaluation (LIFE) Using a Repeated Measures ANCOVA Adjusted for Baseline Scores and Time Effects

    Baseline, 12 weeks (end of treatment), 3 and 6 months post-treatment

  • Least Squares Mean Global Work Functioning Score on the Longitudinal Interval Follow-up Evaluation (LIFE) Using a Repeated Measures ANCOVA Adjusted for Baseline Scores and Time Effects

    Baseline, 12 weeks (end of treatment), 3 and 6 months post-treatment

  • Least Squares Mean Total Score on the Outcomes Questionnaire (OQ) Using a Repeated Measures ANCOVA Adjusted for Baseline Scores and Time Effects

    Baseline, 12 weeks, 3 and 6 months post-treatment

  • Least Squares Mean Psychological Domain Score on the WHO Quality of Life (WHOQOL) Using a Repeated Measures ANCOVA Adjusted for Baseline Scores and Time Effects

    Baseline, 12 weeks (end of treatment), 3 and 6 months post-treatment

  • Least Squares Mean PTSD Severity Score on the Clinician-Administered PTSD Scale (CAPS) for DSM-5 Using a Repeated Measures ANCOVA Adjusted for Baseline Scores and Time Effects

    Baseline,12 weeks (end of treatment), 3 and 6 months post-treatment

Other Outcomes (1)

  • Least Squares Mean Total Score on the Anger Consequences Questionnaire (ACQ) Using a Repeated Measures ANCOVA Adjusted for Baseline Scores and Time Effects

    Baseline, Week 12, 3 and 6 months Post-treatment

Study Arms (2)

Cognitive Behavioral Intervention (CBI)

EXPERIMENTAL

12 weekly individual sessions consisting of psychoeducation, and cognitive and behavioral anger management strategies

Behavioral: Cognitive Behavioral Intervention

Supportive Intervention (SI)

ACTIVE COMPARATOR

12 weekly individual sessions consisting of psychoeducation, problem-solving strategies, and support

Behavioral: Supportive Intervention

Interventions

Includes individual therapy sessions using cognitive and behavioral strategies addressing problems with anger intensity / frequency / management

Also known as: CBI
Cognitive Behavioral Intervention (CBI)

Includes individual therapy sessions using supportive and problem-solving strategies.

Supportive Intervention (SI)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or Female current or former member of the military (active duty, National Guard or Reserve) Deployed to Iraq or Afghanistan
  • Experience trauma during deployment
  • Clinically significant anger
  • At least 2 additional symptoms of PTSD hyperarousal
  • If on medication, no changes within prior 4 weeks

You may not qualify if:

  • Current severe substance use disorder or prior severe substance use disorder not in remission for at least 3 months
  • Current psychotic symptoms
  • current Mania or Bipolar Disorder
  • Current suicidal or homicidal ideation requiring hospitalization
  • Any severe cognitive impairment or history of Organic Mental Disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Providence VA Medical Center, Providence, RI

Providence, Rhode Island, 02908, United States

Location

Related Publications (1)

  • Shea MT, Lambert J, Reddy MK, Presseau C, Sevin E, Stout RL. Treatment of trauma related anger in operation enduring freedom, operation Iraqi freedom, and operation New Dawn veterans: Rationale and study protocol. Contemp Clin Trials Commun. 2018 Aug 24;12:26-31. doi: 10.1016/j.conctc.2018.08.011. eCollection 2018 Dec.

    PMID: 30225391BACKGROUND

Results Point of Contact

Title
M. Tracie Shea, PhD
Organization
Providence VA Medical Center

Study Officials

  • Tracie M. Shea, PhD

    Providence VA Medical Center, Providence, RI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2014

First Posted

June 6, 2014

Study Start

January 1, 2015

Primary Completion

February 28, 2019

Study Completion

February 28, 2019

Last Updated

November 18, 2021

Results First Posted

March 16, 2020

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

I anticipate sharing the data, but have not yet developed a specific plan.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
April 1 2021

Locations